Darden Restaurants reported robust results for its fiscal third quarter ended Feb. 22, with companywide sales rising 5.9% to $3.3 billion and consolidated same-store sales up 4.2% across its 11 brands. LongHorn Steakhouse led the portfolio with 7.2% same-store sales growth, while flagship Olive Garden posted 3.2% comps but saw traffic dip 0.4%. Management attributed Olive Garden’s sales mix to a combination of a newly rolled-out lighter-portion menu (items under $15), stronger catering growth and expanding delivery via Uber Eats (now ~4.7% of orders). Winter storms in January and February subtracted roughly 100 basis points from same-restaurant sales and intermittently forced closures of as many as 40% of restaurants. Darden said Olive Garden added net 17 restaurants during the year, finishing the quarter with 944 units, and raised its companywide same-store sales outlook to about 4.5% for the fiscal year. While LongHorn’s momentum was partly offset by higher beef costs that pressured margins, Darden highlighted strong employee retention and operational execution as drivers of its outperformance versus the broader industry.

French food group Danone has agreed to acquire British meal-replacement and fortified nutrition maker Huel in a deal reported at about €1 billion ($1.1–1.2 billion), the companies announced on March 23, 2026. Huel, founded in 2014 and headquartered in Tring, Hertfordshire, sells plant-based powders, ready-to-drink meals, bars and snacks through a strong direct-to-consumer model and retail distribution across the UK, Europe and the US. The firm reported £214 million of revenue for 2024 and employed roughly 300 people. Danone said it will combine Huel’s digital capabilities and product range with its global distribution, R&D and nutritional expertise; the transaction remains subject to customary closing conditions including regulatory approval. The acquisition follows Danone’s broader push into functional and specialised nutrition — after recent deals such as Kate Farms — and comes as demand grows for convenient, nutrient-complete foods amid trends like GLP-1 driven weight-loss adoption. Media reports cite a price near €1 billion; Danone has not disclosed final financial terms. Danone shares dipped modestly on the announcement.

U.S. restaurant chains ramped up value offers, menu innovation and technology investments in mid-March 2026 as operators navigated inflation, volatile gas prices and uneven traffic. Darden Restaurants reported strong Q3 fiscal results (quarter ended Feb. 22) with companywide same-store sales up 4.2%, led by Olive Garden (+3.2%) and LongHorn Steakhouse (+7.2%) despite a roughly 100-basis-point weather headwind. Brinker’s Maggiano’s Little Italy launched a “Back to Maggiano’s” comeback — boosting pasta portions by ~20% and expanding family-style options to drive value. Chipotle rolled out a limited-time Cilantro Lime Sauce after strong test results and McDonald’s is preparing a $3-or-less value menu and $4 breakfast deals in April to shore up affordability perceptions. Operators also pursued loyalty and tech plays: El Pollo Loco expanded experiential rewards tied to MLS, Papa Johns selected Deliverect to centralize delivery operations through 2027, and vendors and chains pushed agentic AI, chatbot tools, drone tests and reservation-platform consolidation. Analysts remain split on how recent gas-price spikes will affect dining traffic, leaving margins and franchise economics under scrutiny.

Between mid-March and mid-April 2026, a cluster of clinical studies and industry reports has highlighted the expanding, cross‑sector impact of GLP‑1 receptor agonist drugs. Large observational analyses published in Nature Medicine and BMJ Medicine found cardiovascular and kidney risk reductions associated with GLP‑1 use in type 1 diabetes and showed that continuous GLP‑1 therapy in type 2 diabetes yields greater reductions in major adverse cardiovascular events than interrupted or discontinued use. Separate Lancet Psychiatry registry analyses linked semaglutide use to substantially fewer psychiatric hospital visits, depression and anxiety outcomes, while a Cell Reports Medicine study and a human pilot found weight loss with preserved muscle function. Conversely, two Lancet phase‑3 trials showed oral semaglutide did not slow early Alzheimer’s decline. A Danish registry study reported higher preterm birth risk when GLP‑1s were taken for pre‑existing diabetes around conception, but not when used for weight loss. Food industry and retail reports (Mar–Apr 2026) describe manufacturers and grocers pivoting to high‑protein, high‑fiber, low‑sugar products—seafood, dairy protein and prebiotic fibers—to serve a growing GLP‑1 consumer base.

Between March 16–21, 2026, dozens of food sites and test kitchens published spring-themed recipe roundups and plant-based menus while a Seattle startup launched a shelf-stable tofu snack, highlighting converging seasonal and convenience trends in the US food market. Food & Wine, Food Network and PlantBasedNews released collections focused on asparagus, fava beans, ramps, spring peas and pasta, alongside lists for weeknight, picnic and single-serve vegan meals and 5‑ingredient dinners. PlantBasedNews and other outlets republished specific vegan recipes — from teriyaki black bean burgers to one‑pan ramen and tofu ‘taste cubes’ — reflecting broader demand for plant-based, easy-to-make options. Separately, Tofu Go — founded by Caroline Dai — introduced vacuum‑packaged, shelf‑stable tofu bars (12g protein, zero added sugar) in soy barbecue and Sichuan‑style spicy varieties, sold initially DTC with retail ambitions. Dai cited co‑manufacturing challenges for shelf‑stable tofu production and emphasized on‑the‑go packaging for mainstreaming tofu beyond refrigerated cases. Together, the editorial emphasis on spring produce and the emergence of portable plant-protein snacks underscore shifting consumer interest toward seasonal vegetables, convenience and sustainable protein alternatives.